{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:45:27Z","timestamp":1772757927261,"version":"3.50.1"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2013,1,24]],"date-time":"2013-01-24T00:00:00Z","timestamp":1358985600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1007\/s12094-012-0982-0","type":"journal-article","created":{"date-parts":[[2013,1,23]],"date-time":"2013-01-23T17:12:00Z","timestamp":1358961120000},"page":"417-424","source":"Crossref","is-referenced-by-count":39,"title":["Nanoemulsions and nanoparticles for non-melanoma skin cancer: effects of lipid materials"],"prefix":"10.1007","volume":"15","author":[{"given":"P.","family":"Severino","sequence":"first","affiliation":[]},{"given":"J. F.","family":"Fangueiro","sequence":"additional","affiliation":[]},{"given":"S. V.","family":"Ferreira","sequence":"additional","affiliation":[]},{"given":"R.","family":"Basso","sequence":"additional","affiliation":[]},{"given":"M. V.","family":"Chaud","sequence":"additional","affiliation":[]},{"given":"M. H. A.","family":"Santana","sequence":"additional","affiliation":[]},{"given":"A.","family":"Rosmaninho","sequence":"additional","affiliation":[]},{"given":"E. B.","family":"Souto","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2013,1,24]]},"reference":[{"issue":"6","key":"982_CR1","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.addr.2011.01.012","volume":"63","author":"TW Prow","year":"2011","unstructured":"Prow TW, Grice JE, Lin LL, Faye R, Butler M, Becker W et al (2011) Nanoparticles and microparticles for skin drug delivery. Adv Drug Deliv Rev 63(6):470\u2013491","journal-title":"Adv Drug Deliv Rev"},{"issue":"7","key":"982_CR2","first-page":"821","volume":"7","author":"ML Garduno-Ramirez","year":"2012","unstructured":"Garduno-Ramirez ML, Clares B, Dominguez-Villegas V, Peraire C, Ruiz MA, Garcia ML et al (2012) Skin permeation of cacalol, cacalone and 6-epi-cacalone sesquiterpenes from a nanoemulsion. Nat Prod Commun 7(7):821\u2013823","journal-title":"Nat Prod Commun"},{"issue":"5","key":"982_CR3","doi-asserted-by":"crossref","first-page":"5972","DOI":"10.3390\/molecules17055972","volume":"17","author":"Y Chen","year":"2012","unstructured":"Chen Y, Wu Q, Zhang Z, Yuan L, Liu X, Zhou L (2012) Preparation of curcumin-loaded liposomes and evaluation of their skin permeation and pharmacodynamics. Molecules 17(5):5972\u20135987","journal-title":"Molecules"},{"key":"982_CR4","first-page":"4409","volume":"7","author":"YC Chen","year":"2012","unstructured":"Chen YC, Liu DZ, Liu JJ, Chang TW, Ho HO, Sheu MT (2012) Development of terbinafine solid lipid nanoparticles as a topical delivery system. Int J Nanomedicine 7:4409\u20134418","journal-title":"Int J Nanomedicine"},{"issue":"7","key":"982_CR5","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3109\/09687688.2010.522203","volume":"27","author":"P Desai","year":"2011","unstructured":"Desai P, Patlolla RR, Singh M (2011) Interaction of nanoparticles and cell-penetrating peptides with skin for transdermal drug delivery. Mol Membr Biol 27(7):247\u2013259","journal-title":"Mol Membr Biol"},{"key":"982_CR6","first-page":"3023","volume":"7","author":"Y Chen","year":"2012","unstructured":"Chen Y, Zhou L, Yuan L, Zhang ZH, Liu X, Wu Q (2012) Formulation, characterization, and evaluation of in vitro skin permeation and in vivo pharmacodynamics of surface-charged tripterine-loaded nanostructured lipid carriers. Int J Nanomed 7:3023\u20133033","journal-title":"Int J Nanomed"},{"key":"982_CR7","doi-asserted-by":"crossref","unstructured":"Gupta M, Vyas SP (2012) Development, characterization and in vivo assessment of effective lipidic nanoparticles for dermal delivery of fluconazole against cutaneous candidiasis. Chem Phys Lipids 165(4):454\u2013461","DOI":"10.1016\/j.chemphyslip.2012.01.006"},{"issue":"4","key":"982_CR8","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1166\/jbn.2009.1042","volume":"5","author":"A Estella-Hermoso de Mendoza","year":"2009","unstructured":"Estella-Hermoso de Mendoza A, Campanero MA, Mollinedo F, Blanco-Prieto MJ (2009) Lipid nanomedicines for anticancer drug therapy. J Biomed Nanotechnol 5(4):323\u2013343","journal-title":"J Biomed Nanotechnol"},{"issue":"5","key":"982_CR9","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v27.i5.20","volume":"27","author":"KR Pawar","year":"2010","unstructured":"Pawar KR, Babu RJ (2010) Polymeric and lipid-based materials for topical nanoparticle delivery systems. Crit Rev Ther Drug Carrier Syst 27(5):419\u2013459","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"issue":"5","key":"982_CR10","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1468-3083.2009.03100.x","volume":"23","author":"J Leeuw de","year":"2009","unstructured":"de Leeuw J, de Vijlder HC, Bjerring P, Neumann HA (2009) Liposomes in dermatology today. J Eur Acad Dermatol Venereol 23(5):505\u2013516","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1\u20132","key":"982_CR11","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ijpharm.2008.10.003","volume":"366","author":"J Pardeike","year":"2009","unstructured":"Pardeike J, Hommoss A, Muller RH (2009) Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J Pharm 366(1\u20132):170\u2013184","journal-title":"Int J Pharm"},{"issue":"3","key":"982_CR12","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1468-2494.2008.00433.x","volume":"30","author":"EB Souto","year":"2008","unstructured":"Souto EB, Muller RH (2008) Cosmetic features and applications of lipid nanoparticles (SLN, NLC). Int J Cosmet Sci 30(3):157\u2013165","journal-title":"Int J Cosmet Sci"},{"issue":"5","key":"982_CR13","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1021\/js950415w","volume":"85","author":"SD Roy","year":"1996","unstructured":"Roy SD, Gutierrez M, Flynn GL, Cleary GW (1996) Controlled transdermal delivery of fentanyl: characterizations of pressure-sensitive adhesives for matrix patch design. J Pharm Sci 85(5):491\u2013495","journal-title":"J Pharm Sci"},{"issue":"3","key":"982_CR14","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3349\/ymj.2006.47.3.293","volume":"47","author":"SH Lee","year":"2006","unstructured":"Lee SH, Jeong SK, Ahn SK (2006) An update of the defensive barrier function of skin. Yonsei Med J 47(3):293\u2013306","journal-title":"Yonsei Med J"},{"key":"982_CR15","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000323296","volume":"41","author":"B Schittek","year":"2011","unstructured":"Schittek B (2011) The antimicrobial skin barrier in patients with atopic dermatitis. Curr Probl Dermatol 41:54\u201367","journal-title":"Curr Probl Dermatol"},{"issue":"1","key":"982_CR16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/jps.21817","volume":"99","author":"B Baroli","year":"2009","unstructured":"Baroli B (2009) Penetration of nanoparticles and nanomaterials in the skin: fiction or reality? J Pharm Sci 99(1):21\u201350","journal-title":"J Pharm Sci"},{"issue":"31","key":"982_CR17","first-page":"1474","volume":"32","author":"T Passeron","year":"2003","unstructured":"Passeron T, Ortonne JP (2003) Skin ageing and its prevention. Presse Med 32(31):1474\u20131482","journal-title":"Presse Med"},{"issue":"5","key":"982_CR18","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1166\/jbn.2010.1150","volume":"6","author":"J Kristl","year":"2010","unstructured":"Kristl J, Teskac K, Grabnar PA (2010) Current view on nanosized solid lipid carriers for drug delivery to the skin. J Biomed Nanotechnol 6(5):529\u2013542","journal-title":"J Biomed Nanotechnol"},{"issue":"1","key":"982_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0163-7827(02)00028-0","volume":"42","author":"JA Bouwstra","year":"2003","unstructured":"Bouwstra JA, Honeywell-Nguyen PL, Gooris GS, Ponec M (2003) Structure of the skin barrier and its modulation by vesicular formulations. Prog Lipid Res 42(1):1\u201336","journal-title":"Prog Lipid Res"},{"key":"982_CR20","doi-asserted-by":"crossref","unstructured":"Cheng KW, Mattheolabakis G, Wong CC, Ouyang N, Huang L, Constantinides PP et al (2012) Topical phospho-sulindac (OXT-328) is effective in the treatment of non-melanoma skin cancer. Int J Oncol (in press)","DOI":"10.3892\/ijo.2012.1577"},{"issue":"1","key":"982_CR21","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4161\/derm.19831","volume":"4","author":"WB Grant","year":"2012","unstructured":"Grant WB (2012) On the roles of solar UV irradiance and smoking on the diagnosis of second cancers after diagnosis of melanoma. Dermatoendocrinol 4(1):12\u201317","journal-title":"Dermatoendocrinol"},{"issue":"1","key":"982_CR22","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1039\/C1PP05144J","volume":"11","author":"GP Pfeifer","year":"2011","unstructured":"Pfeifer GP, Besaratinia A (2011) UV wavelength-dependent DNA damage and human non-melanoma and melanoma skin cancer. Photochem Photobiol Sci 11(1):90\u201397","journal-title":"Photochem Photobiol Sci"},{"issue":"2","key":"982_CR23","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1590\/S0365-05962012000200004","volume":"87","author":"P Andrade","year":"2012","unstructured":"Andrade P, Brites MM, Vieira R, Mariano A, Reis JP, Tellechea O et al (2012) Epidemiology of basal cell carcinomas and squamous cell carcinomas in a Department of Dermatology: a 5\u00a0year review. An Bras Dermatol 87(2):212\u2013219","journal-title":"An Bras Dermatol"},{"issue":"7","key":"982_CR24","first-page":"476","volume":"41","author":"P Clarke","year":"2012","unstructured":"Clarke P (2012) Nonmelanoma skin cancers\u2014treatment options. Aust Fam Physician 41(7):476\u2013480","journal-title":"Aust Fam Physician"},{"issue":"1","key":"982_CR25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/0974-2077.94323","volume":"5","author":"V Samarasinghe","year":"2012","unstructured":"Samarasinghe V, Madan V (2012) Nonmelanoma skin cancer. J Cutan Aesthet Surg 5(1):3\u201310","journal-title":"J Cutan Aesthet Surg"},{"issue":"5","key":"982_CR26","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1172\/JCI46307","volume":"121","author":"M Grachtchouk","year":"2011","unstructured":"Grachtchouk M, Pero J, Yang SH, Ermilov AN, Michael LE, Wang A et al (2011) Basal cell carcinomas in mice arise from hair follicle stem cells and multiple epithelial progenitor populations. J Clin Invest 121(5):1768\u20131781","journal-title":"J Clin Invest"},{"issue":"2","key":"982_CR27","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1590\/S0365-05962011000200013","volume":"86","author":"VP Chinem","year":"2011","unstructured":"Chinem VP, Miot HA (2011) Epidemiology of basal cell carcinoma. An Bras Dermatol 86(2):292\u2013305","journal-title":"An Bras Dermatol"},{"issue":"3","key":"982_CR28","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1590\/S1807-59322011000300018","volume":"66","author":"ME Florence","year":"2011","unstructured":"Florence ME, Massuda JY, Brocker EB, Metze K, Cintra ML, Souza EM (2011) Angiogenesis in the progression of cutaneous squamous cell carcinoma: an immunohistochemical study of endothelial markers. Clinics (Sao Paulo) 66(3):465\u2013468","journal-title":"Clinics (Sao Paulo)"},{"issue":"5","key":"982_CR29","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1586\/era.11.36","volume":"11","author":"V Samarasinghe","year":"2011","unstructured":"Samarasinghe V, Madan V, Lear JT (2011) Management of high-risk squamous cell carcinoma of the skin. Expert Rev Anticancer Ther 11(5):763\u2013769","journal-title":"Expert Rev Anticancer Ther"},{"issue":"2","key":"982_CR30","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1751-1097.2007.00283.x","volume":"84","author":"N Maddodi","year":"2008","unstructured":"Maddodi N, Setaluri V (2008) Role of UV in cutaneous melanoma. Photochem Photobiol 84(2):528\u2013536","journal-title":"Photochem Photobiol"},{"issue":"5","key":"982_CR31","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s004030050405","volume":"291","author":"K Kruger","year":"1999","unstructured":"Kruger K, Blume-Peytavi U, Orfanos CE (1999) Basal cell carcinoma possibly originates from the outer root sheath and\/or the bulge region of the vellus hair follicle. Arch Dermatol Res 291(5):253\u2013259","journal-title":"Arch Dermatol Res"},{"issue":"2","key":"982_CR32","first-page":"20","volume":"4","author":"RV Patel","year":"2011","unstructured":"Patel RV, Frankel A, Goldenberg G (2011) An update on nonmelanoma skin cancer. J Clin Aesthet Dermatol 4(2):20\u201327","journal-title":"J Clin Aesthet Dermatol"},{"issue":"3","key":"982_CR33","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1097\/SCS.0b013e3182108fa6","volume":"22","author":"Y Alimoglu","year":"2011","unstructured":"Alimoglu Y, Kilic E, Mercan H, Inci E (2011) Metastatic basal cell carcinoma. J Craniofac Surg 22(3):1134\u20131136","journal-title":"J Craniofac Surg"},{"issue":"3","key":"982_CR34","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/modpathol.3801007","volume":"21","author":"J Panelos","year":"2008","unstructured":"Panelos J, Tarantini F, Paglierani M, Di Serio C, Maio V, Pellerito S et al (2008) Photoexposition discriminates Notch 1 expression in human cutaneous squamous cell carcinoma. Mod Pathol 21(3):316\u2013325","journal-title":"Mod Pathol"},{"issue":"1","key":"982_CR35","first-page":"228","volume":"9","author":"S Bolshakov","year":"2003","unstructured":"Bolshakov S, Walker CM, Strom SS, Selvan MS, Clayman GL, El-Naggar A et al (2003) p53 mutations in human aggressive and nonaggressive basal and squamous cell carcinomas. Clin Cancer Res 9(1):228\u2013234","journal-title":"Clin Cancer Res"},{"issue":"6","key":"982_CR36","doi-asserted-by":"crossref","first-page":"595","DOI":"10.2340\/00015555-0966","volume":"90","author":"C Renzi","year":"2010","unstructured":"Renzi C, Mastroeni S, Mannooranparampil TJ, Passarelli F, Caggiati A, Potenza C et al (2010) Delay in diagnosis and treatment of squamous cell carcinoma of the skin. Acta Derm Venereol 90(6):595\u2013601","journal-title":"Acta Derm Venereol"},{"key":"982_CR37","doi-asserted-by":"crossref","first-page":"210813","DOI":"10.1155\/2011\/210813","volume":"2011","author":"VR Yanofsky","year":"2011","unstructured":"Yanofsky VR, Mercer SE, Phelps RG (2011) Histopathological variants of cutaneous squamous cell carcinoma: a review. J Skin Cancer 2011:210813","journal-title":"J Skin Cancer"},{"issue":"1","key":"982_CR38","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.pdpdt.2009.12.004","volume":"7","author":"A Sidoroff","year":"2010","unstructured":"Sidoroff A, Thaler P (2010) Taking treatment decisions in non-melanoma skin cancer\u2014the place for topical photodynamic therapy (PDT). Photodiagn Photodyn Ther 7(1):24\u201332","journal-title":"Photodiagn Photodyn Ther"},{"key":"982_CR39","first-page":"571734","volume":"2011","author":"MH Lien","year":"2011","unstructured":"Lien MH, Sondak VK (2011) Nonsurgical treatment options for basal cell carcinoma. J Skin Cancer 2011:571734","journal-title":"J Skin Cancer"},{"issue":"1","key":"982_CR40","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.sder.2011.01.004","volume":"30","author":"KW O\u2019Bryan","year":"2011","unstructured":"O\u2019Bryan KW, Ratner D (2011) The role of targeted molecular inhibitors in the management of advanced nonmelanoma skin cancer. Semin Cutan Med Surg 30(1):57\u201361","journal-title":"Semin Cutan Med Surg"},{"issue":"5","key":"982_CR41","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1562\/0031-8655(2001)074<0656:THOPAP>2.0.CO;2","volume":"74","author":"R Ackroyd","year":"2001","unstructured":"Ackroyd R, Kelty C, Brown N, Reed M (2001) The history of photodetection and photodynamic therapy. Photochem Photobiol 74(5):656\u2013669","journal-title":"Photochem Photobiol"},{"issue":"6","key":"982_CR42","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1038\/jid.2011.483","volume":"132","author":"MA Weinstock","year":"2012","unstructured":"Weinstock MA, Bingham SF, Digiovanna JJ, Rizzo AE, Marcolivio K, Hall R et al (2012) Tretinoin and the prevention of keratinocyte carcinoma (Basal and squamous cell carcinoma of the skin): a veterans affairs randomized chemoprevention trial. J Invest Dermatol 132(6):1583\u20131590","journal-title":"J Invest Dermatol"},{"issue":"4","key":"982_CR43","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1046\/j.1524-4725.2002.01140.x","volume":"28","author":"TM Chen","year":"2002","unstructured":"Chen TM, Rosen T, Orengo I (2002) Treatment of a large superficial basal cell carcinoma with 5% imiquimod: a case report and review of the literature. Dermatol Surg 28(4):344\u2013346","journal-title":"Dermatol Surg"},{"issue":"6","key":"982_CR44","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1038\/jid.2012.136","volume":"132","author":"PA Wu","year":"2012","unstructured":"Wu PA, Stern RS (2012) Topical tretinoin, another failure in the pursuit of practical chemoprevention for non-melanoma skin cancer. J Investig Dermatol 132(6):1532\u20131535","journal-title":"J Investig Dermatol"},{"issue":"4","key":"982_CR45","doi-asserted-by":"crossref","first-page":"630","DOI":"10.2478\/s11658-010-0033-1","volume":"15","author":"B Osiecka","year":"2010","unstructured":"Osiecka B, Jurczyszyn K, Symonowicz K, Bronowicz A, Ostasiewicz P, Czapinska E et al (2010) In vitro and in vivo matrix metalloproteinase expression after photodynamic therapy with a liposomal formulation of aminolevulinic acid and its methyl ester. Cell Mol Biol Lett 15(4):630\u2013650","journal-title":"Cell Mol Biol Lett"},{"key":"982_CR46","doi-asserted-by":"crossref","first-page":"790509","DOI":"10.1155\/2011\/790509","volume":"2011","author":"D Barolet","year":"2011","unstructured":"Barolet D, Boucher A (2011) No-needle jet intradermal aminolevulinic Acid photodynamic therapy for recurrent nodular Basal cell carcinoma of the nose: a case report. J Skin Cancer 2011:790509","journal-title":"J Skin Cancer"},{"issue":"8","key":"982_CR47","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/j.1445-1433.2004.03130.x","volume":"74","author":"M Jefford","year":"2004","unstructured":"Jefford M, Kiffer JD, Somers G, Daniel FJ, Davis ID (2004) Metastatic basal cell carcinoma: rapid symptomatic response to cisplatin and paclitaxel. ANZ J Surg 74(8):704\u2013705","journal-title":"ANZ J Surg"},{"issue":"1","key":"982_CR48","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ijpharm.2009.10.011","volume":"390","author":"K Teskac","year":"2010","unstructured":"Teskac K, Kristl J (2010) The evidence for solid lipid nanoparticles mediated cell uptake of resveratrol. Int J Pharm 390(1):61\u201369","journal-title":"Int J Pharm"},{"issue":"1\u20132","key":"982_CR49","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijpharm.2007.07.044","volume":"349","author":"G Shi","year":"2008","unstructured":"Shi G, Rao L, Yu H, Xiang H, Yang H, Ji R (2008) Stabilization and encapsulation of photosensitive resveratrol within yeast cell. Int J Pharm 349(1\u20132):83\u201393","journal-title":"Int J Pharm"},{"issue":"1 Suppl 1","key":"982_CR50","first-page":"s15","volume":"7","author":"DS Rigel","year":"2008","unstructured":"Rigel DS, Torres AM, Ely H (2008) Imiquimod 5% cream following curettage without electrodesiccation for basal cell carcinoma: preliminary report. J Drugs Dermatol 7(1 Suppl 1):s15\u2013s16","journal-title":"J Drugs Dermatol"},{"issue":"1","key":"982_CR51","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3109\/08982100903030263","volume":"20","author":"N Dragicevic-Curic","year":"2010","unstructured":"Dragicevic-Curic N, Winter S, Krajisnik D, Stupar M, Milic J, Graefe S et al (2010) Stability evaluation of temoporfin-loaded liposomal gels for topical application. J Liposome Res 20(1):38\u201348","journal-title":"J Liposome Res"},{"issue":"10","key":"982_CR52","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1056\/NEJMc1208003","volume":"367","author":"RI Henkin","year":"2012","unstructured":"Henkin RI (2012) Vismodegib in advanced basal-cell carcinoma. N Engl J Med 367(10):969\u2013971","journal-title":"N Engl J Med"},{"issue":"23","key":"982_CR53","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1056\/NEJMoa1113713","volume":"366","author":"A Sekulic","year":"2012","unstructured":"Sekulic A, Migden MR, Oro AE, Dirix L, Lewis KD, Hainsworth JD et al (2012) Efficacy and safety of vismodegib in advanced basal-cell carcinoma. N Engl J Med 366(23):2171\u20132179","journal-title":"N Engl J Med"},{"issue":"6","key":"982_CR54","first-page":"20","volume":"3","author":"S Amini","year":"2010","unstructured":"Amini S, Viera MH, Valins W, Berman B (2010) Nonsurgical innovations in the treatment of nonmelanoma skin cancer. J Clin Aesthet Dermatol 3(6):20\u201334","journal-title":"J Clin Aesthet Dermatol"},{"key":"982_CR55","doi-asserted-by":"crossref","first-page":"380371","DOI":"10.1155\/2011\/380371","volume":"2011","author":"V Smith","year":"2011","unstructured":"Smith V, Walton S (2011) Treatment of facial basal cell carcinoma: a review. J Skin Cancer 2011:380371","journal-title":"J Skin Cancer"},{"issue":"3","key":"982_CR56","first-page":"282","volume":"5","author":"T Lambert","year":"2006","unstructured":"Lambert T, Mullinax K, Smith J (2006) A case of an adverse reaction to topical 5-fluorouracil in irradiated skin. J Drugs Dermatol 5(3):282\u2013283","journal-title":"J Drugs Dermatol"},{"key":"982_CR57","doi-asserted-by":"crossref","unstructured":"Hosmer JM, Shin SH, Nornoo A, Zheng H, Lopes LB (2010) Influence of internal structure and composition of liquid crystalline phases on topical delivery of paclitaxel. J Pharm Sci (in press)","DOI":"10.1002\/jps.22370"},{"issue":"1","key":"982_CR58","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ejpb.2012.02.008","volume":"81","author":"D Paolino","year":"2012","unstructured":"Paolino D, Celia C, Trapasso E, Cilurzo F, Fresta M (2012) Paclitaxel-loaded ethosomes(R): potential treatment of squamous cell carcinoma, a malignant transformation of actinic keratoses. Eur J Pharm Biopharm 81(1):102\u2013112","journal-title":"Eur J Pharm Biopharm"},{"issue":"2","key":"982_CR59","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.abb.2010.12.030","volume":"508","author":"M Ndiaye","year":"2011","unstructured":"Ndiaye M, Philippe C, Mukhtar H, Ahmad N (2011) The grape antioxidant resveratrol for skin disorders: promise, prospects, and challenges. Arch Biochem Biophys 508(2):164\u2013170","journal-title":"Arch Biochem Biophys"},{"issue":"1","key":"982_CR60","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11095-008-9723-z","volume":"26","author":"P Roy","year":"2009","unstructured":"Roy P, Kalra N, Prasad S, George J, Shukla Y (2009) Chemopreventive potential of resveratrol in mouse skin tumors through regulation of mitochondrial and PI3K\/AKT signaling pathways. Pharm Res 26(1):211\u2013217","journal-title":"Pharm Res"},{"issue":"5297","key":"982_CR61","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1126\/science.275.5297.218","volume":"275","author":"M Jang","year":"1997","unstructured":"Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW et al (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275(5297):218\u2013220","journal-title":"Science"},{"issue":"7","key":"982_CR62","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1046\/j.1365-2230.2002.01151.x","volume":"27","author":"MA Stanley","year":"2002","unstructured":"Stanley MA (2002) Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential. Clin Exp Dermatol 27(7):571\u2013577","journal-title":"Clin Exp Dermatol"},{"issue":"7","key":"982_CR63","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1358\/dot.2012.48.7.1808490","volume":"48","author":"RN Amaria","year":"2012","unstructured":"Amaria RN, Bowles DW, Lewis KD, Jimeno A (2012) Vismodegib in basal cell carcinoma. Drugs Today (Barc) 48(7):459\u2013467","journal-title":"Drugs Today (Barc)"},{"issue":"8","key":"982_CR64","doi-asserted-by":"crossref","first-page":"915","DOI":"10.2217\/fon.12.82","volume":"8","author":"L Dirix","year":"2012","unstructured":"Dirix L, Rutten A (2012) Vismodegib: a promising drug in the treatment of basal cell carcinomas. Future Oncol 8(8):915\u2013928","journal-title":"Future Oncol"},{"issue":"1","key":"982_CR65","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.pdpdt.2010.12.001","volume":"8","author":"E Paszko","year":"2011","unstructured":"Paszko E, Ehrhardt C, Senge MO, Kelleher DP, Reynolds JV (2011) Nanodrug applications in photodynamic therapy. Photodiagn Photodyn Ther 8(1):14\u201329","journal-title":"Photodiagn Photodyn Ther"},{"key":"982_CR66","doi-asserted-by":"crossref","unstructured":"Durbec M, Cosmidis A, Fuchsmann C, Ramade A, Ceruse P (2012) Efficacy and safety of photodynamic therapy with temoporfin in curative treatment of recurrent carcinoma of the oral cavity and oropharynx. Eur Arch Otorhinolaryngol (in press)","DOI":"10.1007\/s00405-012-2083-7"},{"issue":"11","key":"982_CR67","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.tibtech.2008.07.007","volume":"26","author":"D Bechet","year":"2008","unstructured":"Bechet D, Couleaud P, Frochot C, Viriot ML, Guillemin F, Barberi-Heyob M (2008) Nanoparticles as vehicles for delivery of photodynamic therapy agents. Trends Biotechnol 26(11):612\u2013621","journal-title":"Trends Biotechnol"},{"issue":"2","key":"982_CR68","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/bip.21520","volume":"96","author":"G Krishnan","year":"2010","unstructured":"Krishnan G, Roberts MS, Grice J, Anissimov YG, Benson HA (2010) Enhanced transdermal delivery of 5-aminolevulinic acid and a dipeptide by iontophoresis. Biopolymers 96(2):166\u2013171","journal-title":"Biopolymers"},{"issue":"4","key":"982_CR69","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.sder.2011.08.001","volume":"30","author":"Y Lee","year":"2011","unstructured":"Lee Y, Baron ED (2011) Photodynamic therapy: current evidence and applications in dermatology. Semin Cutan Med Surg 30(4):199\u2013209","journal-title":"Semin Cutan Med Surg"},{"issue":"4","key":"982_CR70","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1755-148X.2009.00581.x","volume":"22","author":"MA Tran","year":"2009","unstructured":"Tran MA, Watts RJ, Robertson GP (2009) Use of liposomes as drug delivery vehicles for treatment of melanoma. Pigment Cell Melanoma Res 22(4):388\u2013399","journal-title":"Pigment Cell Melanoma Res"},{"issue":"2","key":"982_CR71","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ejpb.2010.02.007","volume":"75","author":"M Goutayer","year":"2010","unstructured":"Goutayer M, Dufort S, Josserand V, Royere A, Heinrich E, Vinet F et al (2010) Tumor targeting of functionalized lipid nanoparticles: assessment by in vivo fluorescence imaging. Eur J Pharm Biopharm 75(2):137\u2013147","journal-title":"Eur J Pharm Biopharm"},{"issue":"5","key":"982_CR72","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.drup.2005.08.004","volume":"8","author":"F Morgillo","year":"2005","unstructured":"Morgillo F, Lee HY (2005) Resistance to epidermal growth factor receptor-targeted therapy. Drug Resist Updat 8(5):298\u2013310","journal-title":"Drug Resist Updat"},{"key":"982_CR73","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1158\/1078-0432.CCR-07-1441","volume":"14","author":"KJ Cho","year":"2008","unstructured":"Cho KJ, Wang X, Nie S, Chen ZG, Shin DM (2008) Therapeutic nanoparticles for drug delivery in cancer. Clin Cancer Res 14:1310\u20131316","journal-title":"Clin Cancer Res"},{"key":"982_CR74","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2174\/1874471010801010001","volume":"1","author":"K Kairemo","year":"2008","unstructured":"Kairemo K, Erba P, Bergstr\u00f6K J, Pauwels EKJ (2008) Nanoparticles in cancer. Curr Radiopharm 1:30\u201336","journal-title":"Curr Radiopharm"},{"key":"982_CR75","doi-asserted-by":"crossref","unstructured":"Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R (2007) Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2(12):751\u2013760","DOI":"10.1038\/nnano.2007.387"},{"issue":"5","key":"982_CR76","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1021\/nl070375j","volume":"7","author":"JP Ryman-Rasmussen","year":"2007","unstructured":"Ryman-Rasmussen JP, Riviere JE, Monteiro-Riviere NA (2007) Variables influencing interactions of untargeted quantum dot nanoparticles with skin cells and identification of biochemical modulators. Nano Lett 7(5):1344\u20131348","journal-title":"Nano Lett"},{"issue":"1\u20132","key":"982_CR77","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0378-5173(03)00183-2","volume":"258","author":"DD Verma","year":"2003","unstructured":"Verma DD, Verma S, Blume G, Fahr A (2003) Particle size of liposomes influences dermal delivery of substances into skin. Int J Pharm 258(1\u20132):141\u2013151","journal-title":"Int J Pharm"},{"key":"982_CR78","doi-asserted-by":"crossref","unstructured":"Marie-Alexandrine B, Stephanie B, Yves C (2011) Nanoparticles through the skin: managing conflicting results of inorganic and organic particles in cosmetics and pharmaceutics. Wiley Interdiscip Rev Nanomed Nanobiotechnol (in press)","DOI":"10.1002\/wnan.146"},{"issue":"1","key":"982_CR79","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1600-0781.2010.00536.x","volume":"27","author":"J Hia","year":"2011","unstructured":"Hia J, Nasir A (2011) Photonanodermatology: the interface of photobiology, dermatology and nanotechnology. Photodermatol Photoimmunol Photomed 27(1):2\u20139","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"982_CR80","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.cis.2006.05.014","volume":"123\u2013126","author":"A Kogan","year":"2006","unstructured":"Kogan A, Garti N (2006) Microemulsions as transdermal drug delivery vehicles. Adv Colloid Interface Sci 123\u2013126:369\u2013385","journal-title":"Adv Colloid Interface Sci"},{"key":"982_CR81","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.cis.2006.11.016","volume":"128\u2013130","author":"A Spernath","year":"2006","unstructured":"Spernath A, Aserin A (2006) Microemulsions as carriers for drugs and nutraceuticals. Adv Colloid Interface Sci 128\u2013130:47\u201364","journal-title":"Adv Colloid Interface Sci"},{"issue":"5","key":"982_CR82","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1007\/s11095-010-0309-1","volume":"28","author":"N Anton","year":"2010","unstructured":"Anton N, Vandamme TF (2010) Nano-emulsions and micro-emulsions: clarifications of the critical differences. Pharm Res 28(5):978\u2013985","journal-title":"Pharm Res"},{"issue":"3","key":"982_CR83","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ejps.2010.11.014","volume":"42","author":"FA Araujo","year":"2010","unstructured":"Araujo FA, Kelmann RG, Araujo BV, Finatto RB, Teixeira HF, Koester LS (2010) Development and characterization of parenteral nanoemulsions containing thalidomide. Eur J Pharm Sci 42(3):238\u2013245","journal-title":"Eur J Pharm Sci"},{"issue":"6","key":"982_CR84","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1021\/mp8000556","volume":"5","author":"JB Tagne","year":"2008","unstructured":"Tagne JB, Kakumanu S, Nicolosi RJ (2008) Nanoemulsion preparations of the anticancer drug dacarbazine significantly increase its efficacy in a xenograft mouse melanoma model. Mol Pharm 5(6):1055\u20131063","journal-title":"Mol Pharm"},{"issue":"1","key":"982_CR85","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.colsurfb.2009.09.010","volume":"75","author":"F Shakeel","year":"2010","unstructured":"Shakeel F, Ramadan W (2010) Transdermal delivery of anticancer drug caffeine from water-in-oil nanoemulsions. Colloids Surf B Biointerfaces 75(1):356\u2013362","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"1","key":"982_CR86","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ejpb.2010.01.008","volume":"75","author":"LM Araujo","year":"2010","unstructured":"Araujo LM, Thomazine JA, Lopez RF (2010) Development of microemulsions to topically deliver 5-aminolevulinic acid in photodynamic therapy. Eur J Pharm Biopharm 75(1):48\u201355","journal-title":"Eur J Pharm Biopharm"},{"issue":"4","key":"982_CR87","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.foodchem.2009.03.052","volume":"116","author":"C\u2013C Lin","year":"2009","unstructured":"Lin C\u2013C, Lin H-Y, Chen H-C, Yu M-W, Lee M-H (2009) Stability and characterisation of phospholipid-based curcumin-encapsulated microemulsions. Food Chem 116(4):923\u2013928","journal-title":"Food Chem"},{"issue":"1","key":"982_CR88","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.colsurfb.2010.08.018","volume":"82","author":"CH Liu","year":"2011","unstructured":"Liu CH, Chang FY, Hung DK (2011) Terpene microemulsions for transdermal curcumin delivery: effects of terpenes and cosurfactants. Colloids Surf B Biointerfaces 82(1):63\u201370","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"3","key":"982_CR89","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.nano.2010.12.002","volume":"7","author":"S Kakumanu","year":"2011","unstructured":"Kakumanu S, Tagne JB, Wilson TA, Nicolosi RJ (2011) A nanoemulsion formulation of dacarbazine reduces tumor size in a xenograft mouse epidermoid carcinoma model compared to dacarbazine suspension. Nanomedicine 7(3):277\u2013283","journal-title":"Nanomedicine"},{"issue":"2","key":"982_CR90","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.taap.2008.06.019","volume":"232","author":"J Kristl","year":"2008","unstructured":"Kristl J, Teskac K, Milek M, Mlinaric-Rascan I (2008) Surface active stabilizer tyloxapol in colloidal dispersions exerts cytostatic effects and apoptotic dismissal of cells. Toxicol Appl Pharmacol 232(2):218\u2013225","journal-title":"Toxicol Appl Pharmacol"},{"issue":"6","key":"982_CR91","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.addr.2007.04.006","volume":"59","author":"M Schafer-Korting","year":"2007","unstructured":"Schafer-Korting M, Mehnert W, Korting HC (2007) Lipid nanoparticles for improved topical application of drugs for skin diseases. Adv Drug Deliv Rev 59(6):427\u2013443","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"982_CR92","first-page":"20","volume":"2","author":"GB Singhal","year":"2011","unstructured":"Singhal GB, Patel RP, Prajapati BG, Patel NA (2011) Solid lipid nanoparticles and nano lipid carriers: as novel solid lipid based drug carrier. Int Res J Pharm 2(2):20\u201352","journal-title":"Int Res J Pharm"},{"issue":"3","key":"982_CR93","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jsps.2011.04.001","volume":"19","author":"SR Mudshinge","year":"2011","unstructured":"Mudshinge SR, Deore AB, Patil S, Bhalgat CM (2011) Nanoparticles: emerging carriers for drug delivery. Saudi Pharm J 19(3):129\u2013141","journal-title":"Saudi Pharm J"},{"issue":"1\u20132","key":"982_CR94","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.ijpharm.2011.05.010","volume":"414","author":"S Nikolic","year":"2011","unstructured":"Nikolic S, Keck CM, Anselmi C, M\u00fcller RH (2011) Skin photoprotection improvement: synergistic interaction between lipid nanoparticles and organic UV filters. Int J Pharm 414(1\u20132):276\u2013284","journal-title":"Int J Pharm"},{"issue":"1\u20132","key":"982_CR95","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ijpharm.2008.06.028","volume":"363","author":"SD Mandawgade","year":"2008","unstructured":"Mandawgade SD, Patravale VB (2008) Development of SLNs from natural lipids: application to topical delivery of tretinoin. Int J Pharm 363(1\u20132):132\u2013138","journal-title":"Int J Pharm"},{"issue":"1\u20132","key":"982_CR96","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ijpharm.2007.05.061","volume":"345","author":"KA Shah","year":"2007","unstructured":"Shah KA, Date AA, Joshi MD, Patravale VB (2007) Solid lipid nanoparticles (SLN) of tretinoin: potential in topical delivery. Int J Pharm 345(1\u20132):163\u2013171","journal-title":"Int J Pharm"},{"key":"982_CR97","doi-asserted-by":"crossref","unstructured":"Abdel-Mottaleb MMA, Neumann D, Lamprecht A (2011) Lipid nanocapsules for dermal application: a comparative study of lipid-based versus polymer-based nanocarriers. Eur J Pharm Biopharm (In Press, Corrected Proof)","DOI":"10.1016\/j.ejpb.2011.04.009"},{"issue":"1","key":"982_CR98","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ijpharm.2011.06.031","volume":"423","author":"S David","year":"2011","unstructured":"David S, Carmoy N, Resnier P, Denis C, Misery L, Pitard B et al (2011) In vivo imaging of DNA lipid nanocapsules after systemic administration in a melanoma mouse model. Int J Pharm 423(1):108\u2013115","journal-title":"Int J Pharm"},{"issue":"12","key":"982_CR99","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1038\/jid.2010.293","volume":"130","author":"MB Weiss","year":"2010","unstructured":"Weiss MB, Aplin AE (2010) Paying \u201cparticle\u201d attention to novel melanoma treatment strategies. J Invest Dermatol 130(12):2699\u20132701","journal-title":"J Invest Dermatol"},{"issue":"2","key":"982_CR100","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ijpharm.2009.04.026","volume":"379","author":"NT Huynh","year":"2009","unstructured":"Huynh NT, Passirani C, Saulnier P, Benoit JP (2009) Lipid nanocapsules: a new platform for nanomedicine. Int J Pharm 379(2):201\u2013209","journal-title":"Int J Pharm"},{"issue":"6","key":"982_CR101","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1023\/A:1016121319668","volume":"19","author":"B Heurtault","year":"2002","unstructured":"Heurtault B, Saulnier P, Pech B, Proust JE, Benoit JP (2002) A novel phase inversion-based process for the preparation of lipid nanocarriers. Pharm Res 19(6):875\u2013880","journal-title":"Pharm Res"},{"key":"982_CR102","doi-asserted-by":"crossref","unstructured":"Ourique AF, Melero A, de Bona da Silva C, Schaefer UF, Pohlmann AR, Guterres SS et al (2011) Improved photostability and reduced skin permeation of tretinoin: development of a semisolid nanomedicine. Eur J Pharm Biopharm 79(1):95\u2013101","DOI":"10.1016\/j.ejpb.2011.03.008"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-012-0982-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12094-012-0982-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-012-0982-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,6]],"date-time":"2022-02-06T17:08:08Z","timestamp":1644167288000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12094-012-0982-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,24]]},"references-count":102,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["982"],"URL":"https:\/\/doi.org\/10.1007\/s12094-012-0982-0","relation":{},"ISSN":["1699-048X","1699-3055"],"issn-type":[{"value":"1699-048X","type":"print"},{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,24]]}}}